Trials / Unknown
UnknownNCT01373658
Safety and Efficacy Registry of Yinyi Stent (SERY-II)
Safety and Efficacy Registry of Yinyi Polymer-free Paclitaxel-eluting Stent
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and delayed restenosis. Persistent polymer could be responsible. Local delivery of paclitxel from a polymer-free Yinyi stent (Dalian Yinyi biomaterial research and development co.ltd) may prevent these complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Yinyi stent | subjects with Yinyi stent implantation |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-10-01
- Completion
- 2011-12-01
- First posted
- 2011-06-15
- Last updated
- 2011-06-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01373658. Inclusion in this directory is not an endorsement.